to main content Medication - Sterile Compounding - Using Primary and Secondary Engineering Controls with Testing/Certification Failures | Critical Access Hospital | Infection Prevention and Control IC | The Joint Commission
Medication - Sterile Compounding - Using Primary and Secondary Engineering Controls with Testing/Certification Failures

Can we still use our Primary Engineering Control if it fails its testing/certification ?

Any examples are for illustrative purposes only.

It is up to the organization to determine whether or not the compounding space is acceptable to continue producing sterile compounded medication products.  Factors should include the pathogenicity of the organism grown in the positive growth viable sample; complexity level of the compounded product; any known/potential associated hospital acquired infections; and guidance from the infection control practitioner. 
 
Manual: Critical Access Hospital
Chapter: Infection Prevention and Control IC
First published date: January 23, 2018 This Standards FAQ was first published on this date.
This page was last updated on October 29, 2021

If no, please comment on how we could improve this response.

If you have additional standards-related questions regarding this topic, please use the Standards Online Submission Form